NVO - Sen. Sanders goes after Novo Nordisk on study on Ozempic low manufacture cost
2024-03-27 17:02:39 ET
More on Novo Nordisk
- Shaping The Future Of Obesity Treatment: GLP-1 Agonists At The Forefront
- Novo Nordisk: My 'Hold' Thesis For 2024 - The Premium Must Be Justified
- Novo Nordisk, A Very Healthy Pharma Stalwart
- Amazon reportedly leaning on weight loss frenzy to boost pharmacy unit
- Novo Nordisk to buy cardiac drug developer for up to $1.1B